Products for Research Use Only
RegisterLogin

Gilteritinib hemifumarate

CAT: 0931-T71973-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T71973-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1254053-84-3
Target
FLT, TAM Receptor
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Purity
0.9978
Bioactivity
Gilteritinib hemifumarate (ASP2215 hemifumarate) is a potent ATP-competitive dual FLT3 (IC50: 0.29 nM) and AXL (IC50: 0.73 nM) inhibitor for the treatment of relapsed or refractory FLT3 mutant AML.
Smiles
C(=C/C(O)=O)\C(O)=O.N(C=1C(C(N)=O)=NC(CC)=C(NC2CCOCC2)N1)C3=CC(OC)=C(C=C3)N4CCC(CC4)N5CCN(C)CC5
Molecular Formula
C29H44N8O3.1/2C4H4O4
Molecular Weight
610.75
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Chemical Information

Gilteritinib Fumarate

Gilteritinib Fumarate is the fumarate salt form of gilteritinib, an orally bioavailable inhibitor of the receptor tyrosine kinases (RTKs) FMS-like tyrosine kinase 3 (FLT3; STK1; FLK2), AXL (UFO; JTK11), anaplastic lymphoma kinase (ALK; CD246), and leukocyte receptor tyrosine kinase (LTK), with potential antineoplastic activity. Upon administration, gilteritinib binds to and inhibits both the wild-type and mutated forms of FLT3, AXL, ALK and LTK. This may result in an inhibition of FLT3-, AXL-, ALK-, and LTK-mediated signal transduction pathways and reduced proliferation in cancer cells that overexpress these RTKs. FLT3, AXL, ALK, and LTK, which are overexpressed or mutated in a variety of cancer cell types, play key roles in tumor cell growth and survival.

CAS Number1254053-84-3
PubChem CID76970819
IUPAC Name(E)-but-2-enedioic acid;bis(6-ethyl-3-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide)
Molecular FormulaC62H92N16O10
Molecular Weight1221.5
Topological Polar Surface Area317
Hydrogen Bond Donor Count8
Hydrogen Bond Acceptor Count24
Rotatable Bond Count20
Heavy Atom Count88
Formal Charge0
Complexity904
SMILES
CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5.CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5.C(=C/C(=O)O)\C(=O)O
InChI
InChI=1S/2C29H44N8O3.C4H4O4/c2*1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36;5-3(6)1-2-4(7)8/h2*5-6,19-20,22H,4,7-18H2,1-3H3,(H2,30,38)(H2,31,32,34);1-2H,(H,5,6)(H,7,8)/b;;2-1+
InChIKey
UJOUWHLYTQFUCU-WXXKFALUSA-N
Chemical Structure
2D Structure
2D structure of Gilteritinib Fumarate
CAS: 1254053-84-3
CID: 76970819
Formula: C62H92N16O10
MW: 1221.5
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight1221.5
Hydrogen Bond Donor Count8
Hydrogen Bond Acceptor Count24
Rotatable Bond Count20
Exact Mass1220.71823320
Monoisotopic Mass1220.71823320
Topological Polar Surface Area317 Ų
Heavy Atom Count88
Formal Charge0
Complexity904
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count3
Compound Is CanonicalizedYes

Related Products

CatalogName
T4409-01Gilteritinib
T22872-01Isamoltane hemifumarate
T64175Cobimetinib hemifumarate
T12505PLX5622 hemifumarate
T39094-01MSC2360844 hemifumarate
T23536-01Xamoterol hemifumarate
T0143-01Bisoprolol hemifumarate
T6241-01Quetiapine hemifumarate
T64065-01Siponimod hemifumarate
T21911-01Rilmenidine hemifumarate

Alternative Products

CatalogName
C10168-5mgGilteritinib hemifumarate
HY-12432AR-01Gilteritinib hemifumarate (Standard)
A18235-100Gilteritinib hemifumarate 100mg
A18235-1Gilteritinib hemifumarate 1mg
A18235-5Gilteritinib hemifumarate 5mg
A18235-50Gilteritinib hemifumarate 50mg
A18235-25Gilteritinib hemifumarate 25mg
A18235-10Gilteritinib hemifumarate 10mg
B1294-25Gilteritinib

Popular Products